Pharma & Biotech Mergers & Acquisitions News
Pharmaceutical
Big pharmas are not deterred by China’s increasingly complex business environment. Instead, they are changing strategies to minimize risks while continuing to benefit from China, said speakers at ChinaTrials held last week in Shanghai. 18 November 2024
Today's issue
Refine Search
Latest Mergers & Acquisitions News & Features
Generics
French pharma major Sanofi has chosen EUROAPI as the name for the future leading European company dedicated to the development, production and marketing of active pharmaceutical ingredients (API). 12 January 2021
Generics
France-based Provepharm Life Solutions today revealed it has acquired Apollo Pharmaceuticals USA, company that specializes in the commercialization of sterile injectable products for hospital use. 2 December 2020
Generics
Development Partners International (DPI) through its ADP III fund, CDC Group, the UK’s publicly-owned impact investor, and the European Bank for Reconstruction and Development (EBRD) have joined forces in a ground-breaking deal to create a major new player in the pan-African pharmaceuticals industry. 23 November 2020
Generics
The US Federal Trade Commission (FTC) has accepted a proposed consent order, agreeing certain asset divestments, which concludes the FTC’s review of the proposed combination of Netherlands-incorporated generics drugmaker Mylan and US pharma giant Pfizer’s Upjohn Business. 2 November 2020
Generics
Generic drugs major Mylan has reached an agreement to acquire the related intellectual property and commercialization rights of South Africa-headquartered Aspen Pharmacare’s thrombosis business in Europe. 8 September 2020
Generics
Shares of London-listed generics drugmaker Hikma Pharmaceuticals were down 7.38% at £22.97 by early afternoon today, after German family-owned pharma major Boehringer Ingelheim revealed it was selling its equity stake in the generics and injectables company. 23 June 2020
Generics
Perrigo Company today announced that it has reached a definitive agreement to sell its UK-based Rosemont Pharmaceuticals business, a generic prescription pharmaceuticals manufacturer focused on liquid medicines, to an unnamed UK-headquartered private equity firm for £156 million ($195 million) in cash. 19 June 2020
Generics
European regulators have approved the merger of Pfizer’s generics division, Upjohn, with Netherlands-headquartered generics company Mylan. 23 April 2020
Generics
Farmak, the leading Ukrainian drugmaker, plans to accelerate its foreign expansion within the next several years, according to recent statements of some sources close to the company and local media, reports The Pharma Letter’s Russia correspondent. 17 March 2020
Generics
Germany’s Stada Arzneimittel says it is now the largest foreign investor in the Russian pharmaceutical industry, following the completion of a $660 million transaction for a Russian brand portfolio from Japan’s Takeda. 5 March 2020
Generics
As the world is gripped by an escalating epidemic originating in China – the novel coronavirus dubbed COVID-19 that is threatening not just lives but also medicines supplies - French pharma major Sanofi today announced its intention to establish its own manufacturing company for drug ingredients. 24 February 2020
Generics
US generic drugmaker Akorn yesterday announced it has reached an agreement with certain of its lenders to extend the standstill period, and indicated it would seek a buyer. 13 February 2020
Generics
Significant profit margin on branded generic products, new market entrants, and ease in approval of marketing authorization procedures are collectively bolstering the sales of branded generics in the global market. 4 February 2020
Generics
Japan’s Towa Pharmaceutical today announced that it will acquire 100% ownership of Pensa Investments, the generics division of the Spanish privately-held pharmaceutical company Esteve. 23 December 2019
Generics
German generic drugs and consumer healthcare products company Stada Arzneimittel continues its growth trajectory in Europe, with an acquisition. 2 December 2019
Generics
Indian pharma company Lupin has confirmed that it has entered into a definitive agreement for the sale of its entire stake in its Japanese subsidiary Kyowa Pharmaceutical Industry to Unison Capital Partners. 13 November 2019
Generics
A new generics company merging Mylan with Pfizer’s Upjohn will be named Viatris, the firms have announced. 13 November 2019
Generics
Sandoz, the generics and biosimilars arm of Swiss pharma giant Novartis, today announced a binding agreement for the acquisition of the Japanese business of Aspen Global Incorporated (AGI), a wholly-owned subsidiary of South Africa’s Aspen Pharmacare 11 November 2019
Generics
Indian pharma company Lupin is in advanced talks to sell its Japanese generics subsidiary, Kyowa Pharmaceutical, to a local player. 7 November 2019
Generics
Czech drugmaker Zentiva has announced it will buy the Central and Eastern European business of Alvogen, for an undisclosed amount. 25 October 2019
Generics
Aspire Pharma, a UK-based niche generics business, has announced the acquisition of all assets from Canute Pharma, further expanding its product range. 4 October 2024
Generics
Viatris has announced that the antitrust division of the US Department of Justice (DOJ) has concluded its investigation into Mylan and its former president, Rajiv Malik. 3 July 2024
Generics
An activist investor has renewed its effort to prevent Taro Pharmaceutical from accepting a buyout bid from Sun Pharmaceutical. 24 April 2024
Generics
Generic drugmaker Apotex has reached an agreement to acquire fellow Canada-based Searchlight Pharma. 5 April 2024
Generics
KELIX bio, an emerging markets biopharmaceuticals platform, has been sold to Mubadala Investment Company, an Abu Dhabi investor with over $276 billion in assets under management. 25 March 2024
Generics
Generic drugmaker Aspire Pharma today announced the successful completion of its acquisition of fellow UK-based Cenoté Pharma, in continuation of its strong organic growth. 11 March 2024
Generics
In a bid to focus on growth and innovation, Israeli generics drugmaker Teva Pharmaceutical is to hive off its active pharmaceutical ingredient (API) business. 1 February 2024
Generics
Sun Pharmaceutical Industries of India announced its intention to acquire all outstanding shares of US generics drugmaker Taro Pharmaceutical Industries at a price of $43 per share in cash, the companies announced. 19 January 2024
Generics
Taiwan’s Bora Pharmaceuticals is to acquire Upsher-Smith Laboratories, a US generics manufacturer. 17 January 2024
Generics
South Africa's largest drugmaker Aspen Pharmacare has announced an agreement with newly-independent generics drugmaker Sandoz, related to its Chinese business. 7 December 2023
Generics
Portuguese contract development and manufacturing organization (CDMO) Hovione has acquired the start-up ExtremoChem for an undisclosed amount. 20 November 2023
Generics
The Indian pharma and healthcare sector has witnessed a 298% jump in deals during the third quarter of 2023 compared to the same period last year. 8 November 2023
Generics
A confluence of factors is creating a conducive environment for mergers and acquisitions (M&As) to pick up pace in India. 23 October 2023
Generics
USA-based drugmaker Viatris has announced a series of divestitures as part of a strategy to narrow the company’s focus. 3 October 2023
Generics
Indian drugmaker Glenmark Pharmaceuticals has entered into a definitive agreement with Nirma Limited to divest a 75% stake in its subsidiary, Glenmark Life Sciences Limited (GLS), which focuses on producing active pharmaceutical ingredients (APIs). 22 September 2023
Generics
Shares of Hyderabad, India-headquartered Suven Pharmaceuticals hit a fresh 52-week high on the bourses after the Indian government gave the green signal to foreign direct investment (FDI) of up to $1.15 billion by drug major Cyprus-based Berhyanda. 19 September 2023
Generics
Several international investors and fund managers have expressed an interest in investing in the Indian pharmaceutical and biotechnology sectors, underlining the need to establish a platform to facilitate the transition of global capital flows into the domestic economy. 14 April 2023
Generics
In what could well be India's biggest pharma deal, China's Fosun Pharma-owned Gland Pharma is on the block. A number of private equity firms have been approached, including Baring Private Equity, Bain Capital, Blackstone, Carlyle, and KKR. 19 December 2022
Generics
Generics major Viatris yesterday said it intends to create an ophthalmology franchise by acquiring two companies, Oyster Point Pharma (Nasdaq: OYST) and Famy Life Sciences. 8 November 2022
Generics
Private equity firm SK Capital Partners has entered into a deal to acquire Apotex Pharmaceutical Holdings, a Canada-based generic drugmaker with products across all major therapeutic areas for patients around the world. 29 September 2022
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze